ArticleJournal of global infectious diseases
Encapsulation of a Novel
Article in Journal of global infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phage mediated growth inhibition and biofilm disruption of the endodontic pathogen Enterococcus faecalis.PloS one · 2026Article
- Recent perspectives on precision-targeting therapy against oral biofilm.Journal of oral microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: In this study, a novel Results: The phage isolated was lytic belonging to Siphoviridae family. The mean diameter of the chitosan-alginate microspheres was 1.7 ± 0.13 mm. The pore size of the phage-loaded chitosan-alginate shell was less than 100 nm, resulting in sustained release of the phages. The chitosan-alginate encapsulated phage was stable for a long time (6 h) in simulated saliva. The encapsulated phage could withstand exposure to different pH (pH 2, pH 4, and pH 7) in simulated saliva. It was also stable at different temperatures (4°C, 37°C, and 60°C). Conclusion: The encapsulated phage has the potential to be used as phage therapy in oral diseases. Further, the chitosan-alginate encapsulated phage microsphere can be incorporated in a patch/membrane/gel in combination with antibiotics/nutritional components/anti-inflammatory agents as treatment for oral diseases induced by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.